Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat. This evidence concerns the gene AKR1B1 and systemic inflammatory response syndrome.